CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02339571
Title field or adapter rule: {'original_value': 'Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:29.796359+00:00
Published At: 2026-10-26T00:00:00+00:00
Record Updated At: 2026-10-26
Source Retrieved At: 2026-10-31T22:18:13.198083+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Stage III Cutaneous Melanoma AJCC v7", "Stage IV Cutaneous Melanoma AJCC v6 and v7"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-26", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT02339571"
protocolSection.identificationModule.officialTitle: "Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Undergo CT scan', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Undergo ECHO', 'name': 'Echocardiography Test', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Given IV', 'name': 'Ipilimumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Elastography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Undergo MUGA', 'name': 'Multigated Acquisition Scan', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)', 'Arm B (nivolumab, ipilimumab)'], 'description': 'Given IV', 'name': 'Nivolumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['Arm A (nivolumab, ipilimumab, sargramostim)'], 'description': 'Given SC', 'name': 'Sargramostim', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.